Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENVISION: Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

NCT04537832 is registered in ClinicalTrials.gov with Encoded Therapeutics as lead sponsor.

NCT NCT04537832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04537832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENVISION: Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies
Lead sponsor
Encoded Therapeutics
Phase
Observational
Overall status
Terminated
Start date
January 18, 2021
Completion date
March 31, 2023
Enrollment
58 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome